Additives & Concomitant Components vs Impurities in Pharmaceutical Excipients

Wednesday, June 14, 2017 - 11:00am to 1:00pm

Not sure if your company is a member of IPEC-Americas? See the Member Companies page.

This webinar will discuss additives and “impurities”, including concomitant components, as they relate to excipients, why they are important to excipient function, and implications of these various entities (e.g., within the USP General Chapters).

This Webinar is recommended for individuals who work with pharmaceutical excipients in the following function(s):

  • Formulation chemists
  • R&D / technical service personnel
  • Production supervisors and managers
  • Quality and regulatory personnel
  • Sales and marketing executives.

Presentation Objectives

After completion of this webinar you should be able to:

  • Describe commonalities and differences between APIs and excipients
  • Explain reasons for complexity of excipient composition
  • Distinguish between additives, concomitant components, and impurities as related to excipients
  • List important Regulatory concerns Industry faces concerning these ingredients in excipients
  • Describe activities underway to resolve the regulations

Presenter(s)

Joseph Zeleznik

Manager of Technical & Regulatory Affairs
MEGGLE USA, Inc.

For the past four years, Mr. Zeleznik has served as Manager of Technical Affairs with MEGGLE USA. In his role, he is responsible for providing formulation and product application guidance as well as having quality and regulatory oversight for MEGGLE USA’s North American lactose manufacture. Prior to joining MEGGLE USA, Mr. Zeleznik was Associate Director, R&D with JRS PHARMA and Research Manager with Penwest Pharmaceuticals Co. Mr. Zeleznik has over 18 years’ experience in the pharmaceutical industry, having specialized in the development and application of high functionality excipients and in particular, co-processing applications for the enhancement of excipient and pharmacologically active ingredients performance. He holds several patents in areas of product and process development, formulation development, and API co-processing. Mr. Zeleznik has authored or co-authored several articles published in various industry journals. He holds a Master’s Degree in Chemistry from the State University of New York.

George Collins Jr.

VP and Mgr Minerals Division
Vanderbilt Chemicals LLC

BS from UCLA in BioChemistry
1980-1984 Colorado State University Veterinary Teaching Hospital- Equine Research Animal Attendant
1984-1989 RT Vanderbilt Co- R&D and International Sales
1989-present Vanderbilt Chemicals LLC- VP and Mgr Minerals Division
IPEA GMP Certified Auditor Training 2012
IPEC Americas member since 2011
Compendial Review Committee Vice Chair 2015 to present
IPEC USP General Notices Team 2016 to present

Cancellation Policy

Note: No cancellations are available for webcasts (archived recorded webinars). Recordings are available for 21 days after purchase.

Cancellations for live webinars must be made in writing and can be mailed or e-mailed to:

IPEC-Americas Webinars
3138 10th Street
Arlington, VA 22201
Suite 500
E-mail: ipecamer@ipecamericas.org

Registration fees are refundable for attendees registered for individual webinars, if cancellation is received at least five (5) business days prior to the course. Notices of cancellation received 0-4 business days prior to the course will not be provided a refund. If you are unable to attend the webinar, a recording of the webinar will be provided to all registered persons.

Questions?
Please contact IPEC-Americas Training Coordinator
571-814-3449 or email ipecamer@ipecamericas.org